CLX

The Clorox Earnings Track Record: Beats Don’t Always Follow Through

Clorox has delivered a strong headline record over the last eight reported quarters, beating earnings estimates in six of them, or 75% of the time. The average earnings surprise across those reports is 11.4%, which would normally suggest a stock rewarded for consistent outperformance. Yet the post-earnings price behavior tells a different story. Over the five trading days immediately following each report, CLX has averaged a move of -0.63%, classified as a “down” drift. That means even when headline results beat, the stock has not reliably continued higher in the days after.

The most recent quarter, reported on April 30, 2026, is a textbook example. Clorox earned $1.64 per share versus the $1.55 estimate, a 5.8% beat, but the stock fell 9.67% the next day and closed the following five-day window down 4.49%. The quarter before that, on November 3, 2025, a 3.9% beat ($0.85 versus $0.818) produced a modest 1.17% next-day gain but a 4.08% loss over the next five sessions. Even the largest surprise in the sample, the July 31, 2025 report with a 30.5% beat ($2.87 versus $2.20), only delivered a 0.41% gain over the following five days after a -1.96% first-day drop. The negative drift persists even on miss quarters: on February 3, 2026, CLX missed by 2.8% ($1.39 versus $1.43) and still rose 2.43% the next day and 5.63% over five days. In other words, the post-earnings direction has repeatedly diverged from whether the company beat the number.

Options-Flow Dynamics Ahead of the August 3 Report

Clorox’s next scheduled earnings release is August 3, 2026, after the market close, with the official consensus EPS estimate at $1.65. As the event approaches, options flow typically reflects a combination of directional speculation and hedging around that number. Implied volatility normally rises into the print because traders price in the risk of a binary gap, then compresses after the release in a classic post-earnings volatility crush. That crush can be especially punishing for buyers of expensive front-dated premium if the stock does not move enough to cover the elevated straddle cost.

With Clorox currently at $96.32, the same level as its 50-day EMA of $96.32 and an RSI of 51.4, the technical setup is unusually close to a neutral pivot. In options terms, that can concentrate dealer positioning and open interest around nearby strikes, potentially making the price more sensitive to order flow and hedging activity as the report nears. Unusual call or put volume into the event may signal where the market’s real expectation sits relative to the $1.65 consensus, and post-event price action can be shaped as much by how the implied move was priced versus how the stock actually reacts as by the EPS number itself.

What a Disciplined Trader Watches

Given the historical average five-day drift of -0.63%, a disciplined approach to Clorox earnings starts with not assuming that a beat will automatically produce a pop, or that a miss will produce a drop. Traders often compare the next-day realized move to the implied move priced into the options market. When the realized reaction is smaller than expected, premium sellers usually win. When it is larger, directional gamma and dealer hedging can extend the move into the following sessions. The 5-day follow-through therefore matters more than the first gap.

Heading into August 3, watch whether the stock holds, breaks, or rejects the $96.32 50-day EMA area, how implied volatility changes in the final sessions before the print, and whether options flow shows unusually heavy call or put positioning around the consensus estimate. Also watch sector context: as a Consumer Defensive/Household & Personal Products name, Clorox sometimes trades on recession-risk rotation and input-cost commentary as much as the headline EPS beat or miss. For a deeper dive into how institutions are positioned and what the full range of earnings scenarios looks like, readers should review the complete institutional verdict on this ticker.